ChiCTR2100048714
尚未开始
/
/
/
2021-07-13
/
/
Suspected or confirmed infection by methicillin-resistant staphylococcus aureus
Multi-center population pharmacokinetic study of intravenous vancomycin in adults in Hong Kong and development of web-based individual dose optimization interface
Multi-center population pharmacokinetic study of intravenous vancomycin in adults in Hong Kong and development of web-based individual dose optimization interface
1. To develop and validate a model characterizing the population pharmacokinetics of intravenous vancomycin in Hong Kong adults using prospectively collected rich therapeutic drug monitoring data from multiple hospitals under Hospital Authority 2. To develop a web-based interface to enable Bayesian estimates of individual vancomycin exposure and evidence-based optimization of individual empirical and TDM-based dosing regimen 3. To evaluate the clinical utility of the developed interface
历史对照研究
其它
N/A
Not stated
N/A
/
350
/
2021-07-01
2022-08-31
/
(1) At least 18 years old; (2) Admitted to one of the following hospitals under Hospital Authority: Pamela Youde Nethersole Eastern Hospital, Ruttonjee and Tang Shiu Kin Hospitals, Queen Mary Hospital, Queen Elizabeth Hospital, Kwong Wah Hospital, United Christian Hospital, Prince of Wales Hospital, Princess Margaret Hospital, or Tuen Mun Hospital; and (3) prescribed intermittent intravenous vancomycin.；
登录查看(1) Documented trypanophobia or hemophobia; (2) Subjects prescribed any form of renal replacement therapy to be started before or during IV vancomycin treatment.；
登录查看N/A
/
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
